Skip to product information
1 of 10

S-RMab® PD-1 Recombinant Mouse mAb,PBS Only (SDT-R143)

S-RMab® PD-1 Recombinant Mouse mAb,PBS Only (SDT-R143)

Catalog Number: S0B2187P Application: WB, IHC-P, ICC, IP, IF, ICFCM Reactivity: Human Conjugation: Brand: Starter
Price:
Regular price $585 USD
Regular price Sale price $585 USD
Size:

For shipping services or bulk orders, you may request a quotation.
Secure checkout with
View full details

Product Details

Product Specification


Host Mouse
Antigen PD-1
Synonyms Programmed cell death protein 1, hPD-1, CD279
Immunogen N/A
Location Cell membrane
Accession Q15116
Clone Number SDT-R143
Antibody Type Recombinant mAb
Isotype IgG1
Application WB, IHC-P, ICC, IP, IF, ICFCM
Reactivity Hu
Purification Protein G
Concentration 2 mg/ml
Tag N/A
Physical Appearance Liquid
Storage Buffer PBS
Stability & Storage

12 months from date of receipt, 4°C as supplied

Dilution


application dilution species
IHC-P 1:200-1:500
ICFCM 1:200
ICC 1:100
WB 1:1000
IP 1:200
IF 1:200

Background

Programmed cell death protein 1, also known as PD-1 and CD279 (cluster of differentiation 279), is a protein on the surface of T and B cells that has a role in regulating the immune system's response to the cells of the human body by down-regulating the immune system and promoting self-tolerance by suppressing T cell inflammatory activity. This prevents autoimmune diseases, but it can also prevent the immune system from killing cancer cells. PD-1 is an immune checkpoint and guards against autoimmunity through two mechanisms. First, it promotes apoptosis (programmed cell death) of antigen-specific T-cells in lymph nodes. Second, it reduces apoptosis in regulatory T cells (anti-inflammatory, suppressive T cells).

Picture

Western Blot


WB result of PD-1 Mouse mAb
Primary antibody: PD-1 Mouse mAb at 1/1000 dilution
Lane 1: Jurkat whole cell lysate 20 µg
Lane 2: MOLT-4 whole cell lysate 20 µg
Lane 3: MOLT-4 treated with Ionomycin (500ng/ml 24 hr) and PMA (10ng/ml 24 hr) whole cell lysate 20 µg
Negative control: Jurkat whole cell lysate
Secondary antibody: Goat Anti-mouse IgG, (H+L), HRP conjugated at 1/10000 dilution
Predicted MW: 32 kDa
Observed MW: 38~70 kDa

FC

Flow cytometric analysis of Molt-4 (Human cervix adenocarcinoma epithelial cell) cells, treated with 10ng/ml PMA and 500ng/ml Ionomycin for 24h (Red) or untreated (Green), labeling PD-1 at 1/200 dilution (1 μg) compared with a Mouse monoclonal IgG isotype control (Black) and an unlabeled control (cells without incubation with primary antibody and secondary antibody) (Blue). Goat Anti - Mouse IgG Alexa Fluor® 488 was used as the secondary antibody.

IP

PD-1 Mouse mAb at 1/200 dilution (1 µg) immunoprecipitating PD-1 in 0.35 mg MOLT-4 treated with Ionomycin (500ng/ml 24 hr) and PMA (10ng/ml 24 hr) whole cell lysate.
Western blot was performed on the immunoprecipitate using PD-1 Mouse mAb at 1/1000 dilution.
Secondary antibody (HRP) for IP was used at 1/2000 dilution.
Lane 1: MOLT-4 treated with Ionomycin (500ng/ml 24 hr) and PMA (10ng/ml 24 hr) whole cell lysate 20 µg (Input)
Lane 2: PD-1 Mouse mAb IP in MOLT-4 treated with Ionomycin (500ng/ml 24 hr) and PMA (10ng/ml 24 hr) whole cell lysate
Lane 3: Mouse monoclonal IgG1 IP in MOLT-4 treated with Ionomycin (500ng/ml 24 hr) and PMA (10ng/ml 24 hr) whole cell lysate
Predicted MW: 32 kDa
Observed MW: 38~70 kDa
(This blot was developed with high sensitivity substrate)

Immunohistochemistry

IHC shows positive staining in paraffin-embedded human tonsil. Anti-PD-1 antibody was used at 1/200 dilution, followed by a HRP Polymer for Mouse & Rabbit IgG (ready to use). Counterstained with hematoxylin. Heat mediated antigen retrieval with Tris/EDTA buffer pH9.0 was performed before commencing with IHC staining protocol.

IHC shows positive staining in paraffin-embedded human spleen. Anti-PD-1 antibody was used at 1/500 dilution, followed by a HRP Polymer for Mouse & Rabbit IgG (ready to use). Counterstained with hematoxylin. Heat mediated antigen retrieval with Tris/EDTA buffer pH9.0 was performed before commencing with IHC staining protocol.

Negative control: IHC shows negative staining in paraffin-embedded human liver. Anti-PD-1 antibody was used at 1/500 dilution, followed by a HRP Polymer for Mouse & Rabbit IgG (ready to use). Counterstained with hematoxylin. Heat mediated antigen retrieval with Tris/EDTA buffer pH9.0 was performed before commencing with IHC staining protocol.

Immunocytochemistry

ICC shows positive staining in MOLT-4 cells treated with Ionomycin (500ng/ml,24h) + PMA (10ng/ml,24h). Anti-PD-1 antibody was used at 1/100 dilution (Green) and incubated overnight at 4°C. Goat polyclonal Antibody to mouse IgG - H&L (Alexa Fluor® 488) was used as secondary antibody at 1/1000 dilution. The cells were fixed with 4% PFA and permeabilized with 0.1% PBS-Triton X-100. Nuclei were counterstained with DAPI (Blue).

Negative control:ICC shows negative staining in MOLT-4 cells untreated with Ionomycin (500ng/ml,24h) + PMA (10ng/ml,24h). Anti-PD-1 antibody was used at 1/100 dilution and incubated overnight at 4°C. Goat polyclonal Antibody to mouse IgG - H&L (Alexa Fluor® 488) was used as secondary antibody at 1/1000 dilution. The cells were fixed with 4% PFA and permeabilized with 0.1% PBS-Triton X-100. Nuclei were counterstained with DAPI (Blue).

Immunofluorescence

IF shows positive staining in paraffin-embedded human tonsil. Anti-PD-1 antibody was used at 1/200 dilution (magenta) and incubated overnight at 4°C. Goat polyclonal Antibody to Mouse IgG - H&L (Alexa Fluor®647) was used as secondary antibody at 1/500 dilution. Counterstained with DAPI (Blue). Heat mediated antigen retrieval with EDTA buffer pH9.0 was performed before commencing with IF staining protocol.

Negative control: IF shows negative staining in paraffin-embedded human liver. Anti-PD-1 antibody was used at 1/200 dilution and incubated overnight at 4°C. Goat polyclonal Antibody to Mouse IgG - H&L (Alexa Fluor®647) was used as secondary antibody at 1/500 dilution. Counterstained with DAPI (Blue). Heat mediated antigen retrieval with EDTA buffer pH9.0 was performed before commencing with IF staining protocol.